Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
OVID
$1.45
-2.68%
Analyze
1M
-16.2%
3M
+133.9%
1Y
+22.9%
Market Cap:
$103.11M
Ovid Therapeutics Inc
Healthcare |
Biotechnology
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medications for patients and families with neurological disorders in the United States. The company is headquartered in New York, New York.
Click "Analyze" to generate stock analysis
OVID Price Trend and Signals
OVID Option Volumes & Open Interests (aggregated)
OVID Put Call Ratios and IV (aggregated)
OVID Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-10-13
Somewhat Bearish
macd_signal
Dead cross above zero detected.